Tonix Pharmaceuticals Holding (TNXP) Return on Equity (2024 - 2025)
Historic Return on Equity for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 0.49%.
- Tonix Pharmaceuticals Holding's Return on Equity rose 19500.0% to 0.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49%, marking a year-over-year increase of 19500.0%. This contributed to the annual value of 1.12% for FY2024, which is N/A changed from last year.
- As of Q3 2025, Tonix Pharmaceuticals Holding's Return on Equity stood at 0.49%, which was up 19500.0% from 0.47% recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's Return on Equity's 5-year high stood at 0.47% during Q2 2025, with a 5-year trough of 2.44% in Q3 2024.
- In the last 3 years, Tonix Pharmaceuticals Holding's Return on Equity had a median value of 0.77% in 2024 and averaged 1.09%.
- Per our database at Business Quant, Tonix Pharmaceuticals Holding's Return on Equity crashed by -7900bps in 2024 and then skyrocketed by 19500bps in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Return on Equity (Quarter) stood at 0.49% in 2023, then tumbled by -162bps to 1.28% in 2024, then surged by 62bps to 0.49% in 2025.
- Its last three reported values are 0.49% in Q3 2025, 0.47% for Q2 2025, and 0.82% during Q1 2025.